Fundamental Data for MCU

Medicure Inc is a cardiovascular drug discovery and development company focused on developing effective therapeutics for unmet needs in the field of cardiovascular medicine. In addition to MC-4232, they are also conducting Phase II clinical trials with MC-1, which is focused on the prevention and treatment of ischemia, ischemic reperfusion injury, and stroke.

# Employees: 0

Address: ,,,

Phone:

Fax:

Website:

Email:

Sector: Medical

Industry: MED-DRUGS

Executive Officers

No Information

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 11/30/2007

Next Earnings Date(Expected): 7/15/2008

Mean EPS (Next Qtr): ($0.01)

Mean EPS (Year): ($0.10)

Mean Estimate(Long Term): ($0.01)

P/E Ratio(Based on EPS estimate): 0.000

Number of Estimates: 1

Shares Performance

Period	MCU	Compare to S&P
YTD	-0.01 %	-96.11 %
4 Weeks	-0.01 %	-0.01 %
12 Weeks	-0.01 %	-0.01 %

Shares Information

Analyst Coverage: Y

Avg Volume: 321603

Shares Outstanding: 130M

Market Cap: $0.00M

52 Week High: $1.60

52 Week Low: $0.00

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 1/1/1990 MCU split by factor of 0.200

Earnings Performance

EPS Growth in Last Quarter: 50.00 %

EPS Growth in Last Year: 0.00 %

Sales Growth in Last Quarter: 113.41 %

Sales Growth in Last Quarter: -67.37 %

Financials

Qtr Book Value: $0.00

Cash Flow/Share: $0.00

Change in Payout Ratio: -0.010

Price/Sales: -0.010